The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; ipsen; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen-Cilag; Sanofi
Speakers' Bureau - Astellas Pharma; Astellas Pharma; Janssen-Cilag; Janssen-Cilag
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi
Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial.
 
Clare Gilson
No Relationships to Disclose
 
Fiona Ingleby
No Relationships to Disclose
 
Duncan C Gilbert
No Relationships to Disclose
 
Marina Parry
No Relationships to Disclose
 
Nafisah B Atako
No Relationships to Disclose
 
Malcolm David Mason
Honoraria - Bayer
Speakers' Bureau - Sanofi
Other Relationship - Endocyte
 
Zafar Malik
Consulting or Advisory Role - Janssen; Sanofi
Other Relationship - Astellas Oncology; Bayer; Janssen; Sanofi
 
Ruth E Langley
Consulting or Advisory Role - Bayer Schering Pharma (Inst)
Research Funding - Bayer Schering Pharma (Inst)
 
Andrew Simmons
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
Consulting or Advisory Role - Redwood Bioscience
 
Andrea Loehr
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Noel Clarke
No Relationships to Disclose
 
Nicholas James
Honoraria - Astellas Medivation; Bayer; Clovis Oncology; Ipsen; Janssen; Merck; Roche
Consulting or Advisory Role - Bayer; Clovis Oncology; Janssen; Merck; Roche
Speakers' Bureau - Bayer; Ipsen; Janssen; Roche
Research Funding - Astellas Medivation; AstraZeneca; Bayer; Janssen; Merck; Roche
 
Mahesh K B Parmar
Research Funding - Astellas Medivation (Inst); Clovis Oncology (Inst)
 
Matthew Robert Sydes
Honoraria - Janssen; Janssen; Lilly; Sanofi
Research Funding - Astellas Pharma; Clovis Oncology; Janssen-Cilag; Novartis; Pfizer; Sanofi
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Bayer; ESSA; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Sanofi/Aventis (Inst)